{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:16:23Z","timestamp":1793531783727,"version":"4.5.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,8,26]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Identifying new interventions to slow and prevent cognitive decline associated with dementia is critical. Nonpharmacological interventions targeting modifiable risk factors are promising, relatively low-cost, accessible, and safe approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the effects of two 2-year lifestyle interventions on cognitive trajectory in older adults at risk of cognitive decline and dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Single-blind, multicenter randomized clinical trial enrolling 2111 participants from May 2019 to March 2023 (final follow-up, May 14, 2025) at 5 clinical sites in the US. Participant inclusion criteria enriched risk of cognitive decline and included age 60 to 79 years, sedentary lifestyle, and suboptimal diet plus at least 2 additional criteria related to family history of memory impairment, cardiometabolic risk, race and ethnicity, older age, and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were randomly assigned with equal probability to structured (n\u2009=\u20091056) or self-guided (n\u2009=\u20091055) interventions. Both interventions encouraged increased physical and cognitive activity, healthy diet, social engagement, and cardiovascular health monitoring, but differed in structure, intensity, and accountability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary comparison was difference between intervention groups in annual rate of change in global cognitive function, assessed by a composite measure of executive function, episodic memory, and processing speed, over 2 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 2111 individuals enrolled (mean age, 68.2 [SD, 5.2] years; 1455 [68.9%] female), 89% completed the year 2 assessment. The mean global cognitive composite\n                      <jats:italic>z<\/jats:italic>\n                      score increased from baseline over time in both groups, with a mean rate of increase per year of 0.243 SD (95% CI, 0.227-0.258) for the structured intervention and 0.213 SD (95% CI, 0.198-0.229) for the self-guided intervention. The mean rate of increase per year was statistically significantly greater for the structured group than the self-guided group by 0.029 SD (95% CI, 0.008-0.050;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.008). Based on prespecified secondary subgroup comparisons, the structured intervention benefit was consistent for\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers and noncarriers (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.95 for interaction) but appeared greater for adults with lower vs higher baseline cognition (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02 for interaction). Fewer ascertained adverse events were reported in the structured group (serious: 151; nonserious: 1091) vs the self-guided group (serious: 190; nonserious: 1225), with a positive COVID-19 test result being the most common adverse event overall and more frequent in the structured group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among older adults at risk of cognitive decline and dementia, a structured, higher-intensity intervention had a statistically significant greater benefit on global cognition compared with an unstructured, self-guided intervention. Further investigation of functional outcomes, biomarkers, and ongoing extended follow-up will help address clinical relevance and sustainability of the observed cognitive benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT03688126\">NCT03688126<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.12923","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:30:17Z","timestamp":1753727417000},"page":"681","source":"Crossref","is-referenced-by-count":296,"title":["Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function"],"prefix":"10.1001","volume":"334","author":[{"given":"Laura D.","family":"Baker","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Espeland","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Whitmer","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Division of Medical and Scientific Relations, Alzheimer\u2019s Association, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Leng","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lovato","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn V.","family":"Papp","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Department of Neurology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[{"name":"Division of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institute, Stockholm, Sweden"},{"name":"Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland"},{"name":"School of Public Health, Ageing Epidemiology Research Unit, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Kelsey Research Foundation, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Antkowiak","sequence":"additional","affiliation":[{"name":"Rhode Island Chapter, Alzheimer\u2019s Association, Providence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryjo","family":"Cleveland","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Day","sequence":"additional","affiliation":[{"name":"Northern California and Northern Nevada Chapter, Alzheimer\u2019s Association, San Jose"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Elbein","sequence":"additional","affiliation":[{"name":"Houston and Southeast Texas Chapter, Alzheimer\u2019s Association, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tomaszewski Farias","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Davis, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Felton","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn R.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Gitelman","sequence":"additional","affiliation":[{"name":"Advocate Memory Center and the Advocate Aurora Research Institute, Advocate Aurora Health, Downers Grove, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Graef","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Howard","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Katula","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lambert","sequence":"additional","affiliation":[{"name":"Western Carolina Chapter, Alzheimer\u2019s Association, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Matongo","sequence":"additional","affiliation":[{"name":"Illinois Chapter, Alzheimer\u2019s Association, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"McDonald","sequence":"additional","affiliation":[{"name":"Houston and Southeast Texas Chapter, Alzheimer\u2019s Association, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valory","family":"Pavlik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Raman","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Salloway","sequence":"additional","affiliation":[{"name":"Memory and Aging Program, Butler Hospital, and Warren Alpert Medical School of Brown University, Providence, Rhode Island"},{"name":"Department of Psychiatry and Human Behavior, School of Medicine, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Tangney","sequence":"additional","affiliation":[{"name":"Departments of Clinical Nutrition and Family and Preventive Medicine, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ventrelle","sequence":"additional","affiliation":[{"name":"Departments of Clinical Nutrition and Family and Preventive Medicine, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Wilmoth","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Willliams","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Wing","sequence":"additional","affiliation":[{"name":"Memory and Aging Program, Butler Hospital, and Warren Alpert Medical School of Brown University, Providence, Rhode Island"},{"name":"The Miriam Hospital, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Woolard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Division of Medical and Scientific Relations, Alzheimer\u2019s Association, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"24","key":"joi250054r2","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons.","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"15","key":"joi250054r3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","article-title":"Alzheimer\u2019s disease: novel targets and investigational drugs for disease modification.","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"joi250054r4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease.","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"joi250054r5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial.","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"joi250054r6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations.","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"10452","key":"joi250054r7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission.","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"9984","key":"joi250054r8","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"joi250054r9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/alz.12123","article-title":"World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia.","volume":"16","author":"Kivipelto","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"2","key":"joi250054r10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41591-024-03351-6","article-title":"An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial.","volume":"31","author":"Brodaty","year":"2025","journal-title":"Nat Med"},{"issue":"s1","key":"joi250054r11","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.3233\/JAD-180634","article-title":"Systematic Multi-Domain Alzheimer\u2019s Risk Reduction Trial (SMARRT): study protocol.","volume":"70","author":"Yaffe","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"joi250054r12","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1002\/alz.14170","article-title":"An 18-month multimodal intervention trial for preventing dementia: J-MINT PRIME Tamba.","volume":"20","author":"Oki","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"10046","key":"joi250054r13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial.","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"joi250054r14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/alz.13486","article-title":"A multidomain intervention against cognitive decline in an at-risk-population in Germany: results from the cluster-randomized AgeWell.de trial.","volume":"20","author":"Z\u00fclke","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"5","key":"joi250054r15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol"},{"issue":"6","key":"joi250054r16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/alz.13838","article-title":"Japan-Multimodal Intervention Trial for the prevention of dementia: a randomized controlled trial.","volume":"20","author":"Sakurai","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"joi250054r17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14517","article-title":"South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): a randomized controlled trial.","volume":"21","author":"Moon","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"joi250054r18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13195-025-01691-0","article-title":"Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions.","volume":"17","author":"Soldevila-Domenech","year":"2025","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"joi250054r19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/alz.13365","article-title":"Study design and methods: US Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (US POINTER).","volume":"20","author":"Baker","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"6","key":"joi250054r20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70351","article-title":"Baseline characteristics of the US Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (US POINTER): successful enrollment of a diverse clinical trial cohort at risk for cognitive decline.","volume":"21","author":"Whitmer","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"joi250054r21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","article-title":"CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts.","volume":"167","author":"Boutron","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"joi250054r22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14399","article-title":"The POINTER imaging baseline cohort: associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition.","volume":"21","author":"Harrison","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"S10","key":"joi250054r23","doi-asserted-by":"publisher","DOI":"10.1002\/alz.041440","article-title":"Pointer-ZZZ: sleep ancillary to US Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk of Alzheimer\u2019s disease.","volume":"16","author":"Molina-Henry","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"2","key":"joi250054r24","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14574","article-title":"The US POINTER neurovascular ancillary study: study design and methods.","volume":"21","author":"Brinkley","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"joi250054r25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13195-020-00633-2","article-title":"The Alzheimer\u2019s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer\u2019s disease.","volume":"12","author":"Langbaum","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"joi250054r26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-018-0401-z","article-title":"Cognitive composite score association with Alzheimer\u2019s disease plaque and tangle pathology.","volume":"10","author":"Malek-Ahmadi","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"joi250054r27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.dadm.2018.11.006","article-title":"Measuring longitudinal cognition: individual tests versus composites.","volume":"11","author":"Jonaitis","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7","key":"joi250054r28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70216","article-title":"Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTER.","volume":"21","author":"Papp","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"7","key":"joi250054r29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1532-5415.2010.02953.x","article-title":"Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women\u2019s Health Initiative study of cognitive aging extension.","volume":"58","author":"Espeland","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"joi250054r30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study.","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"joi250054r31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1037\/0882-7974.21.4.774","article-title":"Cognitive decline in old age: separating retest effects from the effects of growing older.","volume":"21","author":"Wilson","year":"2006","journal-title":"Psychol Aging"},{"key":"joi250054r32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.909614","article-title":"Practice effect of repeated cognitive tests among older adults: associations with brain amyloid pathology and other influencing factors.","volume":"14","author":"Zheng","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"joi250054r33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jamda.2017.09.020","article-title":"The effect of a 2-year intervention consisting of diet, physical exercise, cognitive training, and monitoring of vascular risk on chronic morbidity\u2014the FINGER randomized controlled trial.","volume":"19","author":"Marengoni","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"joi250054r34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1745691617707316","article-title":"Fitness effects on the cognitive function of older adults: a meta-analytic study\u2014revisited.","volume":"13","author":"Kramer","year":"2018","journal-title":"Perspect Psychol Sci"},{"issue":"5","key":"joi250054r35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.bbi.2011.11.008","article-title":"The association between aerobic fitness and executive function is mediated by prefrontal cortex volume.","volume":"26","author":"Weinstein","year":"2012","journal-title":"Brain Behav Immun"},{"key":"joi250054r36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3389\/fnins.2020.00786","article-title":"Higher adherence to the Mediterranean diet is associated with preserved white matter integrity and altered structural connectivity.","volume":"14","author":"Rodrigues","year":"2020","journal-title":"Front Neurosci"},{"issue":"36","key":"joi250054r37","doi-asserted-by":"publisher","first-page":"954","DOI":"10.15585\/mmwr.mm6536a3","article-title":"Physical inactivity among adults aged 50 years and older\u2014United States, 2014.","volume":"65","author":"Watson","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"joi250054r38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","article-title":"Update of the Healthy Eating Index: HEI-2015.","volume":"118","author":"Krebs-Smith","year":"2018","journal-title":"J Acad Nutr Diet"},{"issue":"19","key":"joi250054r39","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012.","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"joi250054r1","unstructured":"Alzheimer\u2019s Association. 2025 Alzheimer\u2019s Disease Facts and Figures. Accessed July 14, 2025. https:\/\/www.alz.org\/alzheimers-dementia\/facts-figures"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2837046\/jama_baker_2025_oi_250054_1755189973.26265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:00:36Z","timestamp":1756220436000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2837046"}},"subtitle":["The US POINTER Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,26]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.12923","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}